%2B(1).avif)
Modern Wellness Clinic
GLP-1 medications like semaglutide and tirzepatide work — but not overnight. Here's an honest look at what to expect week by week, and why the timeline is worth it.
GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) have changed the landscape of medical weight loss. But there's a gap between what patients expect going in and what the first few months actually look like.
Most people don't lose dramatic weight in week one. They don't feel dramatically different in week two. And by week four, some patients start wondering if the medication is working at all.
It is. Here's what's actually happening, and what a realistic timeline looks like when GLP-1 therapy is properly supervised.
GLP-1 stands for glucagon-like peptide-1 — a hormone your gut naturally releases after eating. It signals to your brain that you're full, slows the rate at which your stomach empties, and improves how your body responds to insulin.
GLP-1 receptor agonists mimic this hormone at a sustained level, which is why they reduce appetite so effectively. The key word is sustained. These medications work over time by consistently lowering your baseline hunger — not by triggering rapid, dramatic changes overnight.
Most GLP-1 protocols begin at a low dose and increase gradually to minimize side effects — particularly nausea, which is the most common reason patients stop early. During this phase, you may notice slightly reduced appetite, but weight loss is typically modest: one to three pounds for most patients.
This phase is about tolerability, not transformation. Don't judge the medication by week two.
Once you're at a therapeutic dose, appetite reduction becomes more pronounced. Many patients describe simply forgetting to eat, or feeling satisfied after portions they would have found unsatisfying before. This is when weight loss starts accelerating — typically 1–2 pounds per week for patients following supportive nutritional guidance.
Clinical research on semaglutide shows an average of approximately 5–6% of body weight lost within the first three months of treatment.
By month three, most patients are well into their therapeutic dose and have established a rhythm. Weight loss continues steadily, and patients often begin noticing changes in body composition — less visceral fat, improved energy, better sleep quality.
Tirzepatide, which targets both GLP-1 and GIP receptors, tends to produce faster and more significant results in this phase. Phase 3 clinical trials showed patients losing an average of 15–20% of body weight over 72 weeks.
GLP-1 medications don't produce infinite weight loss. Most patients reach a plateau at some point between 6 and 18 months, where weekly loss slows or stops. This is normal, not failure.
At this stage, the focus at Modern Wellness Clinic shifts to maintaining results, optimizing body composition through hormone and peptide support if appropriate, and beginning to evaluate long-term management strategies.
GLP-1 medications available through unsupervised online platforms often skip the baseline evaluation that makes these medications safe and effective. Without knowing your thyroid function, metabolic markers, or hormonal baseline, you're missing context that affects both your results and your safety.
At Modern Wellness Clinic, every GLP-1 patient starts with comprehensive labs. We monitor your progress at regular intervals, adjust your dose based on response, and watch for any signals — like excessive muscle loss, blood sugar irregularities, or medication side effects — that warrant a protocol adjustment.
The medication is only part of the equation. The clinical oversight is what makes the difference between patients who sustain results and patients who regain weight once they stop.
Starting weight matters. Patients with more to lose typically see faster initial results. Hormonal health matters too — low thyroid function, high cortisol, or insulin resistance can all blunt the effectiveness of GLP-1 therapy without additional intervention.
Nutrition still plays a role. GLP-1 medications reduce appetite significantly, but patients who use that reduced appetite to make better nutritional choices consistently outperform those who don't change what they eat, just how much.
Finally, adherence to the dosing schedule matters. Missed doses or inconsistent administration can interrupt progress during the critical dose-building phase.
If you've been curious about semaglutide or tirzepatide and want to start with a full medical evaluation rather than a prescription without context, Modern Wellness Clinic is the place to start. Our providers will review your labs, discuss your goals, and help you understand whether a GLP-1 — and at what dose — is the right move for your body specifically.
From conquering the trails at Red Rock to navigating the fast-paced Las Vegas lifestyle, our Summerlin-based clinicians provide the metabolic and hormonal insights you need to perform at your peak. Select a category below to start your journey.
New patients and existing patients welcome. Book online, call us directly, or fill out the form below — our team responds within 24 hours.
Book a consultation to discuss your health goals and get started with a personalized care plan. Most major insurance accepted.
Follow up on your current treatment, request a prescription refill, or schedule your next visit. Our team confirms within 24 hours.
.png)